Email this article Clinical pharmacology and pharmacotherapy: Problems and disputable issues
- Authors: Moiseev VS1, Kobalava Z.D1
-
Affiliations:
- Issue: Vol 87, No 8 (2015)
- Pages: 4-8
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/31774
- ID: 31774
Cite item
Full Text
Abstract
The paper discusses the current problems of internal medicine: the use of biologicals not only in rheumatology, but also in cardiology and pulmonology; current antiviral therapy for diseases of not only the liver, but also the heart (controversial issues); recent clinical data regarding LCZ (versus enalapril) and ivabradine (heart rate reduction).
Keywords
References
- Юдин С.С. Воспоминания. М.: Издательский дом ТОНЧУ; 2012:688.
- Чазов Е.И. Здоровье и власть. М.: ГЭОТАР-Медиа; 2009:496.
- Генно-инженерные биологические препараты в лечении ревматоидного артрита. Под ред. Насонова Е.Л. М.: ИМА-Пресс; 2013:552.
- Hoofnagle J, Seeff L. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med. 2006;355:2444-2451.
- Bacon B, Gordon S, Lawitz E., Marcellin P, Vierling JM, Zeuzem S, Poordad F, Goodman ZD, Sings HL, Boparai N, Burroughs M, Brass CA, Albrecht JK, Esteban R for the HCV RESPOND-2 Investigators Boceprevir for previously treated chronic HCV genotype 1 infection. N Engl J Med. 2011;364:1207-1217. doi: 10.1056/nejmoa1009482.
- Jacobson I, Mchutchison J, Dusheiko G, Di Bisceglie AM, Reddy KR, Bzowej NH, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, Sankoh AJ, Kieffer TL, George S, Kauffman RS, Zeuzem S for the ADVANCE Study Team Telaprevir for previously untreated chronic hepatitis C virus infection. N Engl JMed. 2011;364:2405. doi: 10.1056/nejmoa1012912.
- Cooper L, Knowlton K. Myocarditis. In: Mann D, ed. Braunwald’s Heart Disease. Elsevier; 2015:1589-1602.
- Pankuveit S, Klingel K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev. 2013;18:683-702. doi: 10.1007/s10741-012-9357-4.
- Gupalo EM, Buryachkovskaya LI, Golytsyn S, Balan M, Opavsky MA. Coxsackie-adenovirus receptor (CAR) in patients with cardiomyopathy of inflammatory and non-inflammatory etiology. Eur J Heart Fail. 2013;1(15):602. doi: 10.1016/j.yjmcc.2011.02.011.
- Покровский В.И., Пак С.Г., Брико Н.И. Данилкин Б.К. Инфекционные болезни и эпидемиология. Учебник. М.: ГЭОТАР-Медиа; 2004:295.
- Fisher S, Lipshultz S. Cardiovascular abnormalities in HIV-infected individuals. In: Mann D, ed. Braunwald’s Heart Disease. Elsevier; 2015:1624-1635.
- Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J. 2009;30:1995-2002.
- Hess OM, McKenna W, Schultheiss HP. Myocardial diseases. In: Camm AJ, Leischer TF, eds. The ESC Textbook of Cardiovascular Medicine. Serruys PW; Blackwell Publ., Ljuljana: Blackwell Publ; 2006:453-515.
Supplementary files
